APA (7th ed.) Citation

WL, B., L, N., DM, M., J, D., Z, D., S, H., . . . DA, R. (2022). Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results. Neuro-oncology, 24(1), 101. https://doi.org/10.1093/neuonc/noab118

Chicago Style (17th ed.) Citation

WL, Bi, et al. "Activity of PD-1 Blockade with Nivolumab Among Patients with Recurrent Atypical/anaplastic Meningioma: Phase II Trial Results." Neuro-oncology 24, no. 1 (2022): 101. https://doi.org/10.1093/neuonc/noab118.

MLA (9th ed.) Citation

WL, Bi, et al. "Activity of PD-1 Blockade with Nivolumab Among Patients with Recurrent Atypical/anaplastic Meningioma: Phase II Trial Results." Neuro-oncology, vol. 24, no. 1, 2022, p. 101, https://doi.org/10.1093/neuonc/noab118.